<DOC>
	<DOCNO>NCT00484328</DOCNO>
	<brief_summary>The purpose study determine medicine chronic hepatitis C take daily , instead twice daily .</brief_summary>
	<brief_title>Ribavirin , Its Dosing Regime</brief_title>
	<detailed_description>The standard treatment patient chronic hepatitis C infection ( HCV ) treatment ribavirin . Actually , compliance ( 2x daily ) seem problem . To increase patient ' compliance , investigate total dose ribavirin take daily . The pharmacokinetics ribavirin different dosage regime investigate .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>antiHCV positivity &gt; 6 month Positive HCVRNA genotype 1 4 Liver biopsy within one year start therapy Intention treat participate treatment body weight 75 kg HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>hepatitis C</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Dosage</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>